Exogenous Hormone Use and Mid-life Health in Women: An Epidemiologist's Perspective
Image For Activity Cover
Availability
Registration Required
Online Meeting
May 30, 2025 1:00 PM - 2:00 PM ET
Cost
Member: $0.00
Non-Member: $45.00
In-Training Member: $0.00
Resident Member: $0.00
Resident Non-Member: $45.00
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures

Join us for a thought-provoking webinar that delves into the evolving landscape of exogenous hormone use—focusing on oral contraceptives and menopausal hormone therapy—and its impact on postmenopausal health. Designed especially for early career researchers and those looking to expand their understanding of the literature, this session offers a critical overview of key epidemiologic and clinical studies, with an emphasis on postmenopausal cancer and heart disease risks. Attendees will gain valuable tools to assess study design and findings, uncover research gaps, and explore how a few key clinical guidelines align with the available evidence. While no treatment recommendations will be provided, this session is a must-attend for those seeking to build a stronger foundation in hormone-related women’s health research.

Fellows, Residents, Clinical Researcher, Scientific Researcher

Upon completion of this webinar, participants will be able to:

  1. Summarize key findings from historic and contemporary epidemiologic and clinical studies on postmenopausal health and exogenous hormone use, including oral contraceptives and menopausal hormone therapy.
  2. Critically evaluate the design, methodology, and outcomes of research studies related to postmenopausal health and hormone use.
  3. Identify gaps in the current literature that warrant future research in the field of exogenous hormone use and women's health.
  4. Describe how existing clinical guidelines relate to findings from key studies, while recognizing that no treatment recommendations will be provided. 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Kara Michels, PhD, MPH
Assistant Professor
Albert Einstein College of Medicine

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By